Nano-Mechanical DNA Devices Coupled With CRISPR-Cas12a for CA15-3 Detection

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Analytical Chemistry

Background:

• Accurate monitoring of cancer markers like CA15-3 is vital for breast cancer prognosis and treatment.
• Current CA15-3 detection methods are often time-consuming, costly, and require specialized equipment and personnel.

Purpose of the Study:

• To develop an ultrasensitive, rapid, and cost-effective electrochemical biosensing strategy for CA15-3 detection.
• To integrate nano-mechanical DNA devices with CRISPR-Cas12a technology for enhanced signal amplification and specificity.

Main Methods:

• Designed a biosensor utilizing a Triple Helical Molecular Switch (THMS) for specific CA15-3 recognition.
• Employed a diffusion-limited 3D DNA walking machine coupled with CRISPR-Cas12a for signal amplification.
• Utilized a Co-N/C modified screen-printed electrode (SPE-Co-N/C) as the sensing interface.

Main Results:

• The biosensing strategy achieved an ultrasensitive detection limit of 7.14 × 10⁻⁶ U mL⁻¹ for CA15-3.
• Demonstrated enhanced reaction kinetics due to nanointerface diffusion restriction effects.
• The assay exhibited satisfactory selectivity, reproducibility, and high correlation with ELISA results.

Conclusions:

• The developed electrochemical biosensor provides a promising tool for the early detection and therapeutic monitoring of breast cancer.
• This integrated approach offers a more accessible and efficient alternative to conventional CA15-3 detection methods.